[The best of cardiac failure in 2004]

G Jondeau1

  • 1Hôpital Ambroise Paré, Boulogne. guillaume.jondeau@apr.ap-hop-paris.fr

Archives Des Maladies Du Coeur Et Des Vaisseaux
|February 18, 2005
PubMed

Insights

In 2004, medical device indications expanded for heart failure, including cardioversion and defibrillators. Advances were also made in diagnosing diastolic heart failure and utilizing new medications.

Area of Science:

  • Cardiology
  • Medical Devices
  • Pharmacology

Context:

  • 2004 saw significant advancements in heart failure management and treatment guidelines.
  • Dissemination of indications for medical devices like cardioverters and defibrillators in heart failure.
  • Emerging research in diastolic heart failure diagnosis and treatment.

Purpose:

  • To review key developments in cardiac failure research and clinical practice from 2004.
  • To highlight advancements in medical device applications for heart failure.
  • To summarize progress in pharmacological and therapeutic interventions for heart failure.

Summary:

  • Key 2004 developments include expanded indications for cardioversion and defibrillators (COMPANION, DEFINITE, SCD-HeFT, TOVA studies).
  • Refined use of BNP for diagnosis and prognosis, emphasizing renal function and risks of therapy in non-study populations.
  • Therapeutic advances in heart transplantation, circulatory assistance, diastolic heart failure diagnostics, and new medications (vasopressin antagonists, beta-blockers, cellular cardiomyoplasty).

Impact:

  • The year marked a significant shift in understanding and managing heart failure, integrating new devices and therapies.
  • Emphasis on early treatment initiation before hospital discharge, mirroring practices in coronary artery disease.
  • Improved diagnostic and therapeutic strategies for diverse heart failure patient groups, including those with diastolic dysfunction.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...